Oscar Juarez

Title: Innovations by Oscar Juarez in Viral Deactivation

Introduction

Oscar Juarez is an innovative inventor based in Buffalo Grove, IL (US). He has made significant contributions to the field of virology, particularly in developing methods to deactivate enveloped viruses, including SARS-CoV-2. His work is crucial in the ongoing fight against viral infections.

Latest Patents

Oscar Juarez holds a patent for "Compositions and methods for deactivating enveloped viruses such as SARS-CoV-2." This invention includes a composition and method for preventing and treating infections caused by enveloped viruses. The invention features compounds that have a catalytic domain of a glycosidase and a binding domain that attaches the compound to the surface of the targeted virus. Additionally, it encompasses a pharmaceutical formulation that includes the compound and a pharmaceutically acceptable carrier, designed to deliver the active portion of the compound to the infecting virus within an infected human or animal. The formulation can be administered as an inhalant or a nasal spray. Furthermore, the invention outlines methods for using a glycosidase or its catalytic part to deactivate enveloped viruses by removing glycans from the viral surface protein.

Career Highlights

Oscar Juarez is affiliated with the Illinois Institute of Technology, where he continues to advance his research and innovations. His work is recognized for its potential impact on public health and safety.

Collaborations

Oscar collaborates with notable colleagues, including Karina Tuz and David Do Le Minh, who contribute to his research efforts and innovations.

Conclusion

Oscar Juarez's innovative work in developing methods to deactivate enveloped viruses represents a significant advancement in virology. His contributions are vital in addressing the challenges posed by viral infections, particularly in the context of global health.